Clinical Trial Update: CEUS Evaluation of Bowel Perfusion in Necrotizing Enterocolitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating CEUS for bowel perfusion in necrotizing enterocolitis in newborns was terminated. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bowel Ischemia
• Necrotizing Enterocolitis

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Necrotizing Enterocolitis of Newborn, Bowel Ischemic | Phase 3 | Status: TERMINATED | Results posted: 2024-11-12